Adjuvant Therapy for Stage III Colon Cancer
American Society of Clinical OncologyPublished: April 15, 2019
- Key Points
- Treatment Recommendations
- For patients with stage III resected colon cancer who are being offered treatment
- Summary of Key Evidence from the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) Collaboration
- Exploratory subgroup analyses by risk of recurrence
- Prespecified subgroup analysis by type of oxaliplatin-based chemotherapy
Also Found In
You rely on Guideline Central for transparency
Guideline Central and select third party use “cookies” on this website to enhance the user experience.
This technology helps us gather statistical and analytical information to optimize the relevant content for you.
The user also has the option to opt-out which may have an effect on the browsing experience.